Which statement best describes a plasminogen activator in the context of the contact phase?

Which statement best describes a plasminogen activator in the context of the contact phase?

• A. kallikrein is a plasminogen activator
• B. streptokinase is a plasminogen activator
• C. HMWK is a plasminogen activator
• D. fibrinogen is a plasminogen activator

Answer: (A)

In the contact phase, kallikrein is produced from prekallikrein and serves as a protease that not only helps amplify the intrinsic coagulation cascade but also fuels fibrinolysis by converting plasminogen into plasmin. This direct activation of plasminogen means kallikrein acts as a plasminogen activator within the contact system, linking clot formation and breakdown. While other plasminogen activators like tPA or streptokinase are well-known, they operate outside the contact phase circuitry. Fibrinogen is a substrate for plasmin, not an activator; high molecular weight kininogen is a cofactor in the contact pathway; and streptokinase is a plasminogen activator but not part of the contact-phase process. Thus, kallikrein best fits the role of plasminogen activator in this context.

In the contact phase, kallikrein is produced from prekallikrein and serves as a protease that not only helps amplify the intrinsic coagulation cascade but also fuels fibrinolysis by converting plasminogen into plasmin. This direct activation of plasminogen means kallikrein acts as a plasminogen activator within the contact system, linking clot formation and breakdown. While other plasminogen activators like tPA or streptokinase are well-known, they operate outside the contact phase circuitry. Fibrinogen is a substrate for plasmin, not an activator; high molecular weight kininogen is a cofactor in the contact pathway; and streptokinase is a plasminogen activator but not part of the contact-phase process. Thus, kallikrein best fits the role of plasminogen activator in this context.